Pharmafile Logo
Pharmafocus logo
Advanced Search
lungs

Asthma drugs may have alternative function as pneumonia treatment

March 1, 2017
Research and Development asthma, influenza, pneumonia

Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …

News
kitepharma_fullcolor_rgb_1

Kite Pharma climbs on strong data showing in lymphoma trial

March 1, 2017
Research and Development kite pharma, non-Hodgkin lymphoma

Kite Pharma released the news on Rare Diseases Day promising top-line data from a Phase 1/2 trial of its treatment …

News
jakob-riis

Novo Nordisk’s Head of North America resigns

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment

Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …

News
keytruda1

NICE knocks back MSD’s Keytruda for lung cancer indication

February 28, 2017
Research and Development, Sales and Marketing MSD, NICE, NSCLC, keytruda

MSD’s immunotherapy drug Keytruda (pembrolizumab) has been knocked back by the National Institute of Health and Care Excellence (NICE) for …

News
world_health_organization_flag

WHO releases list of bacteria that pose greatest threat to humankind

February 28, 2017
Research and Development WHO, antibiotic resistance

The World Health Organisation (WHO) has published a list of the 12 bacteria that are thought to present the largest …

News

FDA green lights AstraZeneca type-2 diabetes drug

February 28, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA

AstraZeneca has announced that its type-2 diabetes treatment Qtern (10mg dapagliflozin and 5mg saxagliptin) has received the approval of the …

News
jj_2johnson_and_johnson

J&J latest pharma firm to volunteer pricing data

February 28, 2017
Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson

Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …

News

Sanofi and Lonza partner up for €270m biologics facility

February 28, 2017
Manufacturing and Production Lonza, Sanofi

Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …

News
14171731710_ff2df4d112_o

Huge data loss puts NHS privatisation and Health Secretary under pressure

February 28, 2017
Manufacturing and Production Jeremy Hunt, NHS, data

It has been revealed that a private company, responsible for delivering NHS data, accidentally stored 708,000 pieces of patient data …

News
janssen_latest_logo_on_sign_closer

EMA recommends expanded indication for Janssen multiple myeloma drug

February 27, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Janssen, darzalex

The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of …

News
lajolla-pharmaceutical-company-ljpc-stock-news

La Jolla finds potential jewel in successful Phase 3 trial

February 27, 2017
Manufacturing and Production, Research and Development La Jolla pharmaceutical

La Jolla Pharmaceutical, a biotech company based in San Diego, US, received a boost to both its shares and its …

News
c5rxfeiwyaez8kv

Moderna Therapeutics instates MIT Treasurer to Board of Directors

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MIT, Moderna, Moderna Therapeutics

Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. …

Appointment

Does Trump pose a threat to the FDA’s future?

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump

President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …

Feature
merckincweb1

MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial

February 27, 2017
Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir

MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …

News
hand

Assay opens way to autoantibodies treatment for rheumatoid arthritis

February 27, 2017
Research and Development, Sales and Marketing rheumatoid arthritis

A new discovery, conducted by researchers at the NYU Langone Medical Center and the University of Pittsburgh, has pointed towards …

News
vaccine

Cuba begins Phase 1 testing of HIV vaccine

February 27, 2017
Research and Development, Sales and Marketing Cuba, HIV

Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus …

News
nathalie_moll

EFPIA names first female Director General

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …

Appointment

Weight loss drug reduces diabetes risk by 80%, according to ICL research

February 27, 2017
Research and Development, Sales and Marketing diabetes, icl, liraglutide

Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …

News
celgene_1_02

Celgene announces shock departure of COO

February 27, 2017
Medical Communications, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …

News
astrazeneca-sign

AstraZeneca’s hyperkalaemia treatment rebounds with European recommendation

February 24, 2017
Sales and Marketing AstraZeneca, EMA

AstraZeneca have received some positive news on its hyperkalaemia drug, ZS-9, as it received a recommendation from the Committee for …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026